These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 2716926)

  • 21. Interferon-alpha and interleukin-2 as treatment for leukemia relapse after allogeneic bone marrow transplantation.
    Giralt S; O'Brien S; Talpaz M; Van Besien K; Chan KW; Rondón G; Andersson B; Mehra R; Khouri I; Estey E
    Cytokines Mol Ther; 1995 Jun; 1(2):115-22. PubMed ID: 9384668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha interferon in T helper phenotype chronic lymphocytic leukemia: a report of three cases.
    Cuneo A; Lanza F; Spanedda R; Tomasi P; Ferrari L; Castoldi GL
    J Biol Regul Homeost Agents; 1988; 2(1):31-4. PubMed ID: 2972175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human leukocyte antigen class II allele association to disease progression in Iranian patients with chronic lymphocytic leukemia.
    Hojjat-Farsangi M; Jeddi-Tehrani M; Amirzargar AA; Razavi SM; Sharifian RA; Rabbani H; Shokri F
    Hum Immunol; 2008 Oct; 69(10):666-74. PubMed ID: 18722491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T cell-depleted allogeneic bone marrow transplantation from a partially HLA-mismatched unrelated donor for progressive chronic lymphocytic leukemia and fludarabine-induced bone marrow failure.
    Mehta J; Powles R; Singhal S; Matthey F; Hamblin M; Middleton G; Prendiville J; Glynne P; Zomas A; Treleaven J; Catovsky D
    Bone Marrow Transplant; 1996 May; 17(5):881-3. PubMed ID: 8733715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
    de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
    Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.
    Schetelig J; Thiede C; Bornhauser M; Schwerdtfeger R; Kiehl M; Beyer J; Sayer HG; Kroger N; Hensel M; Scheffold C; Held TK; Hoffken K; Ho AD; Kienast J; Neubauer A; Zander AR; Fauser AA; Ehninger G; Siegert W;
    J Clin Oncol; 2003 Jul; 21(14):2747-53. PubMed ID: 12860954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interferon alfa-2B in chronic lymphatic leukemia of the B-cell type].
    Schlag R; Flieger D; Ziegler-Heitbrock HW; Hill W; Emmerich B; Thiel E
    Dtsch Med Wochenschr; 1990 Jul; 115(28-29):1088-95. PubMed ID: 2373039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation and activation antigens on blood mononuclear cells in lymphocytic leukemia before and during IFN-alpha 2B therapy.
    Demeter J; Paloczi K; Bibok G; Lehoczky D
    Leukemia; 1992; 6 Suppl 3():41S-45S. PubMed ID: 1602826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Favorable response of early stage B CLL patients to treatment with IFN-alpha 2.
    Ziegler-Heitbrock HW; Schlag R; Flieger D; Thiel E
    Blood; 1989 May; 73(6):1426-30. PubMed ID: 2713486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of the intensity of cell surface antigen expression in B-cell chronic lymphocytic leukemia.
    Witzig TE; Li CY; Tefferi A; Katzmann JA
    Am J Clin Pathol; 1994 Mar; 101(3):312-7. PubMed ID: 8135187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of early stage B-cell chronic lymphocytic leukemia with alpha-interferon. Gruppo per lo Studio e la Cura delle Gammapatie Monoclonali.
    Haematologica; 1991; 76(4):298-304. PubMed ID: 1794737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic effect of recombinant interferon alpha on Takatsuki disease].
    Morofuji M; Hirata Y; Ito H; Okuma K; Nakazato Y; Sumida I; Hanada M; Okamura T
    Fukuoka Igaku Zasshi; 1990 Mar; 81(3):145-9. PubMed ID: 2351363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. alpha Interferon in chronic lymphocytic leukaemia.
    Montserrat E; Villamor N; Urbano-Ispizua A; Ribera JM; Rozman C
    Eur J Cancer; 1991; 27 Suppl 4():S74-7. PubMed ID: 1839211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intractable chronic lymphocytic leukemia and interferon.
    Schrek R
    Med Hypotheses; 1991 Jul; 35(3):182-3. PubMed ID: 1719359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Peripheral neuropathy during interferon alpha therapy].
    Jaubert D; Hauteville D; Pelissier JF; Muzellec Y
    Presse Med; 1991 Feb; 20(5):221-2. PubMed ID: 1826156
    [No Abstract]   [Full Text] [Related]  

  • 36. Alpha interferon in primary myelofibrosis.
    Turri D; Mitra ME; Di Trapani R; Cajozzo A
    Haematologica; 1989; 74(4):417-8. PubMed ID: 2507422
    [No Abstract]   [Full Text] [Related]  

  • 37. Alpha-2b interferon in the treatment of advanced chronic lymphocytic leukemia.
    Klener P; Háber J; Hausner P
    Neoplasma; 1989; 36(2):215-20. PubMed ID: 2716926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J; Babusíková O
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant alpha-2a interferon in treatment of B-chronic lymphocytic leukemia. A preliminary report with emphasis on previously untreated patients in early stage of disease.
    Molica S; Alberti A
    Haematologica; 1990; 75(1):75-8. PubMed ID: 2338291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon maintenance therapy for patients with chronic lymphocytic leukemia in remission after fludarabine therapy.
    O'Brien S; Kantarjian H; Beran M; Robertson LE; Koller C; Lerner S; Keating MJ
    Blood; 1995 Aug; 86(4):1298-300. PubMed ID: 7632936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.